NCCN Guidelines Insights Breast Cancer, Version 1.2016.

Published

Journal Article

These NCCN Guideline Insights highlight the important updates to the systemic therapy recommendations in the 2016 NCCN Guidelines for Breast Cancer. In the most recent version of these guidelines, the NCCN Breast Cancer Panel included a new section on the principles of preoperative systemic therapy. In addition, based on new evidence, the panel updated systemic therapy recommendations for women with hormone receptor-positive breast cancer in the adjuvant and metastatic disease settings and for patients with HER2-positive metastatic breast cancer. This report summarizes these recent updates and discusses the rationale behind them.

Full Text

Duke Authors

Cited Authors

  • Gradishar, WJ; Anderson, BO; Balassanian, R; Blair, SL; Burstein, HJ; Cyr, A; Elias, AD; Farrar, WB; Forero, A; Giordano, SH; Goetz, M; Goldstein, LJ; Hudis, CA; Isakoff, SJ; Marcom, PK; Mayer, IA; McCormick, B; Moran, M; Patel, SA; Pierce, LJ; Reed, EC; Salerno, KE; Schwartzberg, LS; Smith, KL; Smith, ML; Soliman, H; Somlo, G; Telli, M; Ward, JH; Shead, DA; Kumar, R

Published Date

  • December 2015

Published In

Volume / Issue

  • 13 / 12

Start / End Page

  • 1475 - 1485

PubMed ID

  • 26656517

Pubmed Central ID

  • 26656517

Electronic International Standard Serial Number (EISSN)

  • 1540-1413

Language

  • eng

Conference Location

  • United States